MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss applicable
to common...
-$30,974K
Net loss
-$30,836K
Preferred stock dividends
$138K
Total operating loss
-$20,085K
Total other expense
-$10,751K
Interest income
$126K
Total operating
expenses
$20,085K
Interest expense
$7,329K
Change in fair value of
derivatives
-$3,548K
Research and development
$14,290K
General and
administrative
$5,795K
Back
Back
Income Statement
source: myfinsight.com
GALECTIN THERAPEUTICS INC (GALT)
GALECTIN THERAPEUTICS INC (GALT)